ArticleBlood2024

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.

LaQuisa C Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.